Three noted UW-Madison biotech researchers including stem-cell pioneer James Thomson have begun construction on a laboratory to house a new drug screening company in Madison's University Research Park . In partnership with Tactics II Ventures LP a venture capital firm that specializes in early-stage life science companies UW research